QuickView for %27de novo%27 protein folding (biogroup)

1. Proteasome inhibition affects on estrogen-dependent gene transcription
2. Monocytes exposed to traffic-related particulate matter
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
5. Malignant melanoma A375 cells depleted of HSF1 and treated with HSP90 inhibitors

1. De novo protein fold families expand the designable ligand binding site space.
2. De Novo Protein Design for Novel Folds Using Guided Conditional Wasserstein Generative Adversarial N…
3. Coiled-Coil Protein Origami: Design, Isolation, and Characterization.
4. Computational design of soluble functional analogues of integral membrane proteins.
5. RNA-mediated chaperone type for de novo protein folding.

There were no clinical trials for %27de novo%27 protein folding